These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 23965722)

  • 1. [5 days of systemic steroids in COPD exacerbation are adequate].
    Steurer J
    Praxis (Bern 1994); 2013 Aug; 102(17):1075. PubMed ID: 23965722
    [No Abstract]   [Full Text] [Related]  

  • 2. COPD exacerbations: 5 days of corticosteroid therapy.
    Prescrire Int; 2014 Oct; 23(153):246-7. PubMed ID: 25964977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients hospitalized for exacerbations of chronic obstructive pulmonary disease: comparison of an oral/metered-dose inhaler regimen and an intravenous/nebulizer regimen.
    Shortall SP; Blum J; Oldenburg FA; Rodgerson L; Branscombe JM; Harrow EM
    Respir Care; 2002 Feb; 47(2):154-8. PubMed ID: 11812271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: a cohort study.
    Gulati S; Zouk AN; Kalehoff JP; Wren CS; Davison PN; Kirkpatrick DP; Bhatt SP; Dransfield MT; Wells JM
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2271-2278. PubMed ID: 30100717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there an optimal corticosteroid regimen for the management of an acute exacerbation of chronic obstructive pulmonary disease?
    Vondracek SF; Hemstreet BA
    Pharmacotherapy; 2006 Apr; 26(4):522-32. PubMed ID: 16553512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation.
    Abroug F; Ouanes-Besbes L; Fkih-Hassen M; Ouanes I; Ayed S; Dachraoui F; Brochard L; Elatrous S
    Eur Respir J; 2014 Mar; 43(3):717-24. PubMed ID: 23794465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease.
    Adelman A
    J Fam Pract; 1999 Oct; 48(10):750-1. PubMed ID: 12224669
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.
    Niewoehner DE; Erbland ML; Deupree RH; Collins D; Gross NJ; Light RW; Anderson P; Morgan NA
    N Engl J Med; 1999 Jun; 340(25):1941-7. PubMed ID: 10379017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short-term oral prednisone therapy on blood gene expression: a randomised controlled clinical trial.
    Takiguchi H; Chen V; Obeidat M; Hollander Z; FitzGerald JM; McManus BM; Ng RT; Sin DD
    Respir Res; 2019 Aug; 20(1):176. PubMed ID: 31382977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bolus methylprednisolone efficacy for uncontrolled exacerbation of cystic fibrosis in children.
    Ghdifan S; Couderc L; Michelet I; Leguillon C; Masseline B; Marguet C
    Pediatrics; 2010 May; 125(5):e1259-64. PubMed ID: 20385626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of two corticosteroid regimens in acute exacerbation of chronic obstructive pulmonary disease.
    Aggarwal P; Wig N; Bhoi S
    Int J Tuberc Lung Dis; 2011 May; 15(5):687-92. PubMed ID: 21756523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
    N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral versus i.v. steroids for children hospitalized with asthma.
    Agrawal M; French L
    J Fam Pract; 1999 Aug; 48(8):578-9. PubMed ID: 10496630
    [No Abstract]   [Full Text] [Related]  

  • 15. [How to discontinue steroid medication].
    MMW Fortschr Med; 2013 Jun; 155(12):20. PubMed ID: 23923299
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of corticosteroids in chronic obstructive pulmonary disease.
    Calverley PM
    Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral vs IV corticosteroids for in-hospital treatment of COPD exacerbations.
    Nicholas SS
    Chest; 2008 Aug; 134(2):470. PubMed ID: 18682476
    [No Abstract]   [Full Text] [Related]  

  • 18. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease.
    Aaron SD; Vandemheen KL; Hebert P; Dales R; Stiell IG; Ahuja J; Dickinson G; Brison R; Rowe BH; Dreyer J; Yetisir E; Cass D; Wells G
    N Engl J Med; 2003 Jun; 348(26):2618-25. PubMed ID: 12826636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical inquiries. Do systemic corticosteroids lessen symptoms in acute exacerbations of COPD?
    McDiarmid T; Mackler L; Briscoe D
    J Fam Pract; 2003 Dec; 52(12):979-80. PubMed ID: 14653988
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.